Saturday 14 November 2026 Daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

Cardinal Health procedure trays caught in BD Alaris infusion set withdrawal, Health Canada says

A Becton Dickinson request to stop using certain infusion sets has led to a top-tier Canadian recall of nine Cardinal Health tray configurations, with no incidents reported in the notice.

12 Nov 2026 · Health Canada · Regulator

A decision by Becton Dickinson (BD) to pull infusion sets used with its Alaris pump module model 8100 has now reached the kitted-products market. Health Canada has listed a Type I recall of Cardinal Health General Procedure Trays, which contain the affected sets. The notice carries the reference RA-82737.

Cardinal Health was recently informed of BD's recall, according to the notice. BD has asked for the sets to be discontinued, and the regulator files the problem under product performance. The recalling firm is Cardinal Health 200, LLC, based in Waukegan, Illinois. The recall date is 24 September 2026. Health Canada first posted the entry on 6 October and updated it on 12 November.

Nine tray entries are named, identified by lot or serial numbers 22870, 31972, 34186, 30288, 33612, 46036, 45108, 45062 and 964798. They correspond to catalogue numbers RES307732C, RES3077323, RES3077322, RES3077321 and RES307732A.

Context: Type I is the most serious of Health Canada's recall classes. It is used where a product could cause grave harm or death. The notice is aimed at healthcare audiences and tells anyone needing more information to contact the manufacturer. It gives no further corrective steps, no unit counts and no reports of harm, so the commercial scale of the recall cannot be judged from the listing.

Why it matters

  • A single supplier's withdrawal of a component can pull finished kits and trays from other companies into a recall.
  • Hospital and distributor inventory teams in Canada can check stock against the nine lot or serial numbers and five catalogue numbers in the notice.
  • Kit assemblers may want to confirm whether their own products include BD Alaris infusion sets and how recall notices from component suppliers reach them.
  • The notice is brief, so details on required actions and any financial impact must come from the manufacturer.

Official record: Health Canada ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →